Medidata Solutions is a leading global provider of cloud-based clinical development solutions that enhance the efficiency of customers’ clinical trials. Medidata’s advanced platform lowers the total cost of clinical development by optimizing clinical trials from concept to conclusion: from study and protocol design, trial planning and budgeting, site negotiation, clinical portal, trial management, randomization and trial supply management, clinical data capture and management, safety events capture, medical coding to business analytics. Our diverse life science customer base spans biopharmaceutical companies, medical device and diagnostic companies, academic and government institutions, CROs and other research organizations, and includes 24 of the top 25 global pharmaceutical companies as well as organizations of all sizes developing life-enhancing medical treatments and diagnostics. The company was founded in 1999 and is based in New York with additional offices in the United States, the United Kingdom, and Japan.

New York, US
1,254 (est)+2%

Medidata Locations

New York, US
Woodbridge Township, US
Conshohocken, US
Houston, US
Ross, US
San Francisco, US
Chiyoda-ku, JP
Beijing, CN
Singapore, SG
London, GB

Medidata Metrics

Medidata Summary

Founding Date


Market capitalization

$2.89 B

Closing share price


Medidata Financials

FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015

Interest expense

$237 K$123 K$138 K$5.93 M$15.4 M$16.2 M

Income tax expense

$905 K$-16.4 M$10 M$1.72 M$422 K$2.61 M

Medidata Market Value History

Market Position – Health, pharma, clinics, diagnostics, life sciences, platform, cloud, healthtech

Medidata Online Presence

Medidata Company Life

You may also be interested in